The controversial drug ivabradine just got a little more controversial. The drug, which is marketed by Servier under the brand names of Corlentor and Procoralan, is available in Europe and elsewhere and is used for the treatment of heart failure and stable angina. The drug is not available in the US, but it is under development by Amgen for a heart…
SIGNIFY Trial Provokes Sound And Fury Over Controversial Servier and Amgen Drug
August 31, 2014 by Leave a Comment
FDA Grants Fast Track Status To Amgen Heart Failure Drug
April 17, 2014 by Leave a Comment
Amgen announced yesterday that its new chronic heart failure drug ivabradine had been granted fast track status by the FDA. The company said the fast track designation, which is for drugs that treat serious conditions and fill an umet medical need, will aid the development and speed the review of the drug. … Click here to read the…
Recent Comments